Clinical Trial Update: Biomarkers in Predicting Response to Rituximab Treatment in Samples From Patients With Indolent Follicular Lymphoma

View source ↗

Summary

This clinical trial update reports on biomarkers that may predict response to rituximab in samples from patients with indolent follicular lymphoma, from a compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Lymphoma | Status: COMPLETED